Skip to main content
. 2018 Aug 30;14(8):e1007268. doi: 10.1371/journal.ppat.1007268

Fig 6. PH-797804 treatment reduces inflammatory cytokines and markers in plasma of SIV-infected RMs.

Fig 6

ELISA longitudinal assessment of inflammatory cytokines levels in plasma of IFNα, IFNγ, TNFα, IL-6, IP-10 (pg/ml) and inflammatory markers CRP and sCD163 (μg/ml). Data are represented as mean ± SEM. The reported p values were calculated for the comparisons of the AUC from week 18 (first available time point after beginning of PH-797804 treatment) to 60 and refer to AUC comparisons in Group 3 vs. Group 4 and Group 5 vs. Group 6.